These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 30269638)

  • 1. Preoperative Oral Pregabalin Reduces Acute Pain after Thoracotomy.
    Sattari H; Hashemian M; Lashkarizadeh MR; Jalalifard H
    Open Access Maced J Med Sci; 2018 Sep; 6(9):1606-1610. PubMed ID: 30337973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Change in Papillary Thyroid Cancer Terminology on Anxiety Levels and Treatment Preferences: A Randomized Crossover Trial.
    Nickel B; Barratt A; McGeechan K; Brito JP; Moynihan R; Howard K; McCaffery K
    JAMA Otolaryngol Head Neck Surg; 2018 Oct; 144(10):867-874. PubMed ID: 30335875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trans Tasman Radiation Oncology Group Cancer Research: Phase III - Muscle Invasive Bladder Cancer trial (TROG 02.03): A moral dilemma.
    Gogna NK; Duchesne G; O'Brien P; Spry N; Turner S; Matthews J; Borg M; Bauman K; King M; Burmeister E
    J Med Imaging Radiat Oncol; 2018 Oct; 62(5):668-670. PubMed ID: 30288941
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm.
    Boyle F; Beith J; Burslem K; de Boer R; Hui R; Lim E; McCarthy N; Redfern A; Woodward N
    Asia Pac J Clin Oncol; 2018 Oct; 14 Suppl 4():3-11. PubMed ID: 30288930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer.
    Lim E; Beith J; Boyle F; de Boer R; Hui R; McCarthy N; Redfern A; Wade T; Woodward N
    Asia Pac J Clin Oncol; 2018 Oct; 14 Suppl 4():12-21. PubMed ID: 30288929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resting state functional connectivity in patients with remitted psychotic depression: A multi-centre STOP-PD study.
    Neufeld NH; Mulsant BH; Dickie EW; Meyers BS; Alexopoulos GS; Rothschild AJ; Whyte EM; Hoptman MJ; Nazeri A; Downar J; Flint AJ; Voineskos AN
    EBioMedicine; 2018 Oct; 36():446-453. PubMed ID: 30287158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Ketamine as an Adjunct to Treating Opioid Refractory Cancer-Related Pain in the Emergency Department.
    Brockett-Walker C
    Adv Emerg Nurs J; 2019; 41(2):101-106. PubMed ID: 31033656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Evaluation of Palliative Care for Patients with Cancer Disease: A Systematic Review.
    Soltani Arabshahi SK; Nikjoo S; Rezapour A; Rashki Kemmak A; Jahangiri R; Farabi H; Husseini Barghazan S
    Med J Islam Repub Iran; 2022; 36():141. PubMed ID: 36569396
    [No Abstract]   [Full Text] [Related]  

  • 9. Ketamine.
    Quibell R; Fallon M; Mihalyo M; Twycross R; Wilcock A
    J Pain Symptom Manage; 2015 Aug; 50(2):268-78. PubMed ID: 26096492
    [No Abstract]   [Full Text] [Related]  

  • 10. Ketamine for cancer pain: what is the evidence?
    Jonkman K; van de Donk T; Dahan A
    Curr Opin Support Palliat Care; 2017 Jun; 11(2):88-92. PubMed ID: 28306568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economic evaluation of the randomised, double-blind, placebo-controlled study of subcutaneous ketamine in the management of chronic cancer pain.
    McCaffrey N; Flint T; Kaambwa B; Fazekas B; Rowett D; Currow DC; Hardy J; Agar MR; Quinn S; Eckermann S
    Palliat Med; 2019 Jan; 33(1):74-81. PubMed ID: 30269638
    [No Abstract]   [Full Text] [Related]  

  • 12. Implementing practice change in chronic cancer pain management: clinician response to a phase III study of ketamine.
    Hardy JR; Spruyt O; Quinn SJ; Devilee LR; Currow DC
    Intern Med J; 2014 Jun; 44(6):586-91. PubMed ID: 24720500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study protocol for a randomised, double-blinded, placebo-controlled, clinical trial of S-ketamine for pain treatment in patients with chronic pancreatitis (RESET trial).
    Juel J; Olesen SS; Olesen AE; Poulsen JL; Dahan A; Wilder-Smith O; Madzak A; Frøkjær JB; Drewes AM
    BMJ Open; 2015 Mar; 5(3):e007087. PubMed ID: 25757947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential economic impact on hospitalisations of the Palliative Care Clinical Studies Collaborative (PaCCSC) ketamine randomised controlled trial.
    McCaffrey N; Hardy J; Fazekas B; Agar M; Devilee L; Rowett D; Currow D
    Aust Health Rev; 2016 Feb; 40(1):100-105. PubMed ID: 26093387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care.
    Salas S; Frasca M; Planchet-Barraud B; Burucoa B; Pascal M; Lapiana JM; Hermet R; Castany C; Ravallec F; Loundou A; Auquier P; Duffaud F; Baumstarck K
    J Palliat Med; 2012 Mar; 15(3):287-93. PubMed ID: 22335487
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.